← Back to Dividend Calendar

Johnson & Johnson

JNJNYSE

HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Market Cap

$533.03B

Revenue (TTM)

$96.36B

EBITDA

$34.33B

Profit Margin

21.8%

P/E Ratio

25.63

Earnings Growth (YoY)

-52.9%

Return on Equity

26.4%

Dividend Yield

2.4%

Upcoming Events (1)Past Events (109)

Earnings Report

Johnson & Johnson

Pre-Market

Report Date:

Fiscal Period:

EPS Estimate:

Rev. Estimate:

Price Target:

Oct 13, 2026

Q3 2026

$2.78(prior yr: $2.80)

$25.4B

$288.28